healthcare-professionals
 
 

Hot flashes and night sweats can be difficult for patients without a treatment with the effectiveness of Elestrin.

  • Elestrin is indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.
  • Provides significant reductions in the frequency of hot flashes by week 3 and severity of hot flashes by Week 4 using the 2-pump dose, and by Week 5 using the 1-pump dose.1,2
  • It is specially formulated to offer maximum convenience, and to fit easily into your patient’s daily routine.

References:

1.    Simon JA, Bouchard C, Waldbaum A, et al. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial. Obstet Gynecol. 2007;109:588-596.

2.    Elestrin™ [package insert]. San Antonio TX: Kenwood Therapeutics, 2007.

 

Important Safety InformationElestrin is indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.

Estrogens, with or without progestins, should not be used for the prevention of cardiovascular disease or dementia. Estrogen and progestin therapy has shown an increased risk of breast cancer, heart attack, and blood clots. Estrogen therapy, with or without progestins, increases the risk of stroke and dementia. Estrogen therapy alone increases the risk of endometrial cancer. The most frequently reported adverse events in clinical trials were nasopharyngitis, breast tenderness, upper respiratory tract infection, and metrorrhagia.

Please see Full Prescribing Information, including Black Box Warning

 
 

Close (x)

A Survey of 300 untreated menopausal women reveal what they want from the application of transdermal estrogen therapy†:

"I want a product I can apply and forget it."

"I’d rather just rub the product in and forget it’s there."

"For me, it’s easier to get into a daily habit."

"I like the control of applying [it] right on my upper arm."

"Make it clear and easy to apply."

†A blinded survey of 300 women with hot flashes to evaluate the importance of various attributes of transdermal estrogen therapy and the preference for various topical estrogen therapy products. Azur Pharma; 2009.

Close (x)

Disclaimer

Please note: The following section is for
healthcare providers only.